Chemotherapeutic loading via tailoring of drug-carrier interactions in poly (sialic acid) micelles

Gerald Pawlish; Kyle Spivack; Adam Gabriel; Zuyi Huang; Noelle Comolli; Gerald Pawlish; Kyle Spivack; Adam Gabriel; Zuyi Huang; Noelle Comolli

doi:10.3934/bioeng.2018.2.106

AIMS Bioengineering

2018, Volume 5, Issue 2: 106-132. doi: 10.3934/bioeng.2018.2.106

Previous Article Next Article

Research article

Chemotherapeutic loading via tailoring of drug-carrier interactions in poly (sialic acid) micelles

1.
Department of Bioengineering, College of Engineering, Temple University, 1947 N 12th St, Philadelphia, PA 19122, USA
2.
Department of Chemical Engineering, College of Engineering, Villanova University, 800 E. Lancaster Ave., Villanova, PA 19085, USA

Received: 05 February 2018 Accepted: 10 May 2018 Published: 22 May 2018

New methods in nanoparticle development have aimed to develop customized carriers suited for specific purposes. Micelles, due to their highly tailorable nature, are prime candidates for this customizable methodology. In order to maximize drug loading and tailor release, groups of the micelle core should be carefully selected in order to exploit inherent interactions between the selected drug and the carrier core. Small variations within the composition of these groups can greatly affect micelle characteristics (e.g., size, stability, loading and release). While covalent bonding of drug-to-carrier has enhanced drug loading, drawbacks include inhibited release and altered drug properties. As a result, drug/carrier non-covalent interactions such as hydrophobic attraction, hydrogen bonding and π-π stacking have all garnered great interest, allowing for both enhanced loading as well as bond dissociation to aid in drug release. Just as important, external composition of these micelles should be suited for specific therapeutic applications. Examples include providing stabilization, enhanced circulation times and site-specific targeting. Poly (sialic acid) (PSA), a naturally occurring polysaccharide, has been shown to exhibit all three of these properties yet remains relatively unexplored in the field of micelle-based cancer drug delivery applications. Here, we have grafted various phenyl-terminated alkyl groups (PTAGs) onto the backbone of PSA (PTAG-g-PSA), each selected in order to exploit a specific non-covalent interaction (hydrophobic attraction, hydrogen bonding and π-π stacking) between the PTAG group and the anthracycline chemotherapeutic doxorubicin (DOX) (Figure 1). Upon aqueous self-assembly, these amphiphiles formed micelles which exhibited variation in size, stability, cytotoxicity and DOX loading/release based upon the PTAG selected. For example, PTAGs selected to exploit either hydrogen bonding or π-π stacking loaded in a similar fashion yet varied greatly in release properties. Therefore, the synergistic effect of these small-scale modifications in core groups selected can greatly effect micelle characteristics and result in highly tailorable carriers.
- cancer,
- hydrogen bonding,
- micelles,
- nanomedicine,
- non-covalent bonding,
- pi-pi stacking,
- poly (sialic acid)
Citation: Gerald Pawlish, Kyle Spivack, Adam Gabriel, Zuyi Huang, Noelle Comolli. Chemotherapeutic loading via tailoring of drug-carrier interactions in poly (sialic acid) micelles[J]. AIMS Bioengineering, 2018, 5(2): 106-132. doi: 10.3934/bioeng.2018.2.106

Related Papers:

Abstract

New methods in nanoparticle development have aimed to develop customized carriers suited for specific purposes. Micelles, due to their highly tailorable nature, are prime candidates for this customizable methodology. In order to maximize drug loading and tailor release, groups of the micelle core should be carefully selected in order to exploit inherent interactions between the selected drug and the carrier core. Small variations within the composition of these groups can greatly affect micelle characteristics (e.g., size, stability, loading and release). While covalent bonding of drug-to-carrier has enhanced drug loading, drawbacks include inhibited release and altered drug properties. As a result, drug/carrier non-covalent interactions such as hydrophobic attraction, hydrogen bonding and π-π stacking have all garnered great interest, allowing for both enhanced loading as well as bond dissociation to aid in drug release. Just as important, external composition of these micelles should be suited for specific therapeutic applications. Examples include providing stabilization, enhanced circulation times and site-specific targeting. Poly (sialic acid) (PSA), a naturally occurring polysaccharide, has been shown to exhibit all three of these properties yet remains relatively unexplored in the field of micelle-based cancer drug delivery applications. Here, we have grafted various phenyl-terminated alkyl groups (PTAGs) onto the backbone of PSA (PTAG-g-PSA), each selected in order to exploit a specific non-covalent interaction (hydrophobic attraction, hydrogen bonding and π-π stacking) between the PTAG group and the anthracycline chemotherapeutic doxorubicin (DOX) (Figure 1). Upon aqueous self-assembly, these amphiphiles formed micelles which exhibited variation in size, stability, cytotoxicity and DOX loading/release based upon the PTAG selected. For example, PTAGs selected to exploit either hydrogen bonding or π-π stacking loaded in a similar fashion yet varied greatly in release properties. Therefore, the synergistic effect of these small-scale modifications in core groups selected can greatly effect micelle characteristics and result in highly tailorable carriers.

References

[1]	Caliceti P, Salmaso S (2013) Stealth properties to improve therapeutic efficacy of drug nanocarriers. J Drug Deli 2013: 1–19.
[2]	Jayant S, Khandare JJ, Wang Y, et al. (2007) Targeted sialic acid-doxorubicin prodrugs for intracellular delivery and cancer treatment. Pharm Res 24: 2120–2130. doi: 10.1007/s11095-007-9406-1
[3]	Li Y, Yang L (2015) Driving forces for drug loading in drug carriers. J Microencapsu 32: 255–272. doi: 10.3109/02652048.2015.1010459
[4]	Wang XH, Tian Q, Wang W, et al. (2012) In vitro evaluation of polymeric micelles based on hydrophobically-modified sulfated chitosan as a carrier of doxorubicin. J Mater Sci-Mater M 23: 1663–1674. doi: 10.1007/s10856-012-4627-1
[5]	Li JF, Yang HY, Zhang YJ, et al. (2015) Choline Derivate-Modified Doxorubicin Loaded Micelle for Glioma Therapy. Acs Appl Mater Inter 7: 21589–21601. doi: 10.1021/acsami.5b07045
[6]	Su Y, Hu Y, Du Y, et al. (2015) Redox-responsive polymer drug conjugates based on doxorubicin and chitosan oligosaccharide-g-stearic acid for cancer therapy. Mol Pharm 12: 1193–1202. doi: 10.1021/mp500710x
[7]	Gou P, Liu W, Mao W, et al. (2013) Self-assembling doxorubicin prodrug forming nanoparticles for cancer chemotherapy: Synthesis and anticancer study in vitro and in vivo. J Mater Chem B 1: 284–292. doi: 10.1039/C2TB00004K
[8]	Sun Y, Zou W, Bian SQ, et al. (2013) Bioreducible PAA-g-PEG graft micelles with high doxorubicin loading for targeted antitumor effect against mouse breast carcinoma. Biomaterials 34: 6818–6828. doi: 10.1016/j.biomaterials.2013.05.032
[9]	Jain RK, Stylianopoulos T (2010) Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol 7: 653–664. doi: 10.1038/nrclinonc.2010.139
[10]	Du YZ, Weng Q, Yuan H, et al. (2010) Synthesis and antitumor activity of stearate-g-dextran micelles for intracellular doxorubicin delivery. Acs Nano 4: 6894–6902. doi: 10.1021/nn100927t
[11]	Wang YC, Wang F, Sun TM, et al. (2011) Redox-responsive nanoparticles from the single disulfide bond-bridged block copolymer as drug carriers for overcoming multidrug resistance in cancer cells. Bioconjugate Chem 22: 1939–1945. doi: 10.1021/bc200139n
[12]	Zhang AP, Zhang Z, Shi FH, et al. (2013) Redox-sensitive shell-crosslinked polypeptide-block-polysaccharide micelles for efficient intracellular anticancer drug delivery. Macromol Biosci 13: 1249–1258. doi: 10.1002/mabi.201300175
[13]	Shuai XT, Ai H, Nasongkla N, et al. (2004) Micellar carriers based on block copolymers of poly(e-caprolactone) and poly(ethylene glycol) for doxorubicin delivery. J Control Release 98: 415–426. doi: 10.1016/j.jconrel.2004.06.003
[14]	Song HT, Hoang NH, Yun JM, et al. (2016) Development of a new tri-block copolymer with a functional end and its feasibility for treatment of metastatic breast cancer. Colloids Surface B 144: 73–80. doi: 10.1016/j.colsurfb.2016.04.002
[15]	Zhao XY, Poon Z, Engler AC, et al. (2012) Enhanced stability of polymeric micelles based on postfunctionalized poly(ethylene glycol)-b-poly(gamma-propargyl L-glutamate): The substituent effect. Biomacromolecules 13: 1315–1322. doi: 10.1021/bm201873u
[16]	Hamaguchi T, Matsumura Y, Suzuki M, et al. (2005) NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel. Brit J Cancer 92: 1240–1246. doi: 10.1038/sj.bjc.6602479
[17]	Shi Y, van Steenbergen MJ, Teunissen EA, et al. (2013) Pi-Pi stacking increases the stability and loading capacity of thermosensitive polymeric micelles for chemotherapeutic drugs. Biomacromolecules 14: 1826–1837. doi: 10.1021/bm400234c
[18]	Carstens MG, de Jong P, van Nostrum CF, et al. (2008) The effect of core composition in biodegradable oligomeric micelles as taxane formulations. Eur J Pharm Biopharm 68: 596–606. doi: 10.1016/j.ejpb.2007.08.014
[19]	Yokoyama M, Fukushima S, Uehara R, et al. (1998) Characterization of physical entrapment and chemical conjugation of adriamycin in polymeric micelles and their design for in vivo delivery to a solid tumor. J Control Release 50: 79–92. doi: 10.1016/S0168-3659(97)00115-6
[20]	Kataoka K, Matsumoto T, Yokoyama M, et al. (2000) Doxorubicin-loaded poly(ethylene glycol)-poly(beta-benzyl-l-aspartate) copolymer micelles: Their pharmaceutical characteristics and biological significance. J Control Release 64: 143–153. doi: 10.1016/S0168-3659(99)00133-9
[21]	Hofman JW, Carstens MG, van Zeeland F, et al. (2008) Photocytotoxicity of mTHPC (temoporfin) loaded polymeric micelles mediated by lipase catalyzed degradation. Pharm Res 25: 2065–2073. doi: 10.1007/s11095-008-9590-7
[22]	Mikhail AS, Allen C (2010) Poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelles containing chemically conjugated and physically entrapped docetaxel: Synthesis, characterization, and the influence of the drug on micelle morphology. Biomacromolecules 11: 1273–1280. doi: 10.1021/bm100073s
[23]	Wang C, Chen B, Zou M, et al. (2014) Cyclic RGD-modified chitosan/graphene oxide polymers for drug delivery and cellular imaging. Colloid Surface B 122: 332–340. doi: 10.1016/j.colsurfb.2014.07.018
[24]	Yan JL, Ye ZY, Chen M, et al. (2011) Fine tuning micellar core-forming block of poly(ethylene glycol)-block-poly(epsilon-caprolactone) amphiphilic copolymers based on chemical modification for the solubilization and delivery of doxorubicin. Biomacromolecules 12: 2562–2572. doi: 10.1021/bm200375x
[25]	Bader RA, Silvers AL, Zhang N (2011) Polysialic acid-based micelles for encapsulation of hydrophobic drugs. Biomacromolecules 12: 314–320. doi: 10.1021/bm1008603
[26]	Veronese FM, Pasut G (2005) PEGylation, successful approach to drug delivery. Drug Discov Today 10: 1451–1458. doi: 10.1016/S1359-6446(05)03575-0
[27]	Deepagan VG, Thambi T, Ko H, et al. (2013) Amphiphilic polysialic acid derivatives: Synthesis, characterization, and in-vitro cytotoxicity. J Nanosci Nanotechno 13: 7312–7318. doi: 10.1166/jnn.2013.8089
[28]	Gregoriadis G, McCormack B, Wang Z, et al. (1993) Polysialic acids-potential in drug delivery. Febs Lett 315: 271–276. doi: 10.1016/0014-5793(93)81177-2
[29]	Konradi R, Acikgoz C, Textor M (2012) Polyoxazolines for nonfouling surface coatings-a direct comparison to the gold standard PEG. Macromol Rapid Comm 33: 1663–1676. doi: 10.1002/marc.201200422
[30]	Bondioli L, Ruozi B, Belletti D, et al. (2011) Sialic acid as a potential approach for the protection and targeting of nanocarriers. Expert Opin Drug Del 8: 921–937. doi: 10.1517/17425247.2011.577061
[31]	Semple SC, Harasym TO, Clow KA, et al. (2005) Immunogenicity and rapid blood clearance of liposomes containing polyethylene glycol-lipid conjugates and nucleic acid. J Pharmacol Exp Ther 312: 1020–1026.
[32]	Amoozgar Z, Yeo Y (2012) Recent advances in stealth coating of nanoparticle drug delivery systems. Wires Nanomed Nanobio 4: 219–233. doi: 10.1002/wnan.1157
[33]	Zhang N, Wardwell PR, Bader RA (2013) Polysaccharide-based micelles for drug delivery. Pharmaceutics 5: 329–352. doi: 10.3390/pharmaceutics5020329
[34]	Wilson DR, Zhang N, Silvers AL, et al. (2014) Synthesis and evaluation of cyclosporine A-loaded polysialic acid-polycaprolactone micelles for rheumatoid arthritis. Eur J Pharm Sci 51: 146–156. doi: 10.1016/j.ejps.2013.09.013
[35]	Bondioli L, Costantino L, Ballestrazzi A, et al. (2010) PLGA nanoparticles surface decorated with the sialic acid, N-acetylneuraminic acid. Biomaterials 31: 3395–3403. doi: 10.1016/j.biomaterials.2010.01.049
[36]	Deninno MP (1991) The synthesis and glycosidation of n-acetylneuraminic acid. Synthesis 1991: 583–593. doi: 10.1055/s-1991-26522
[37]	Rutishauser U (1998) Polysialic acid at the cell surface: Biophysics in service of cell interactions and tissue plasticity. J Cell Biochem 70: 304–312. doi: 10.1002/(SICI)1097-4644(19980901)70:3<304::AID-JCB3>3.0.CO;2-R
[38]	Vodovozova EL, Moiseeva EV, Grechko GK, et al. (2000) Antitumour activity of cytotoxic liposomes equipped with selectin ligand SiaLe(X), in a mouse mammary adenocarcinoma model. Eur J Cancer 36: 942–949. doi: 10.1016/S0959-8049(00)00029-0
[39]	Hirai M, Minematsu H, Hiramatsu Y, et al. (2010) Novel and simple loading procedure of cisplatin into liposomes and targeting tumor endothelial cells. Int J Pharm 391: 274–283. doi: 10.1016/j.ijpharm.2010.02.030
[40]	Zheng JS, Zheng SY, Zhang YB, et al. (2011) Sialic acid surface decoration enhances cellular uptake and apoptosis-inducing activity of selenium nanoparticles. Colloid Surface B 83: 183–187. doi: 10.1016/j.colsurfb.2010.11.023
[41]	Greco F, Arif I, Botting R, et al. (2013) Polysialic acid as a drug carrier: evaluation of a new polysialic acid-epirubicin conjugate and its comparison against established drug carriers. Polym Chem-UK 4: 1600–1609. doi: 10.1039/C2PY20876H
[42]	Zeisig R, Stahn R, Wenzel K, et al. (2004) Effect of sialyl Lewis X-glycoliposomes on the inhibition of E-selectin-mediated tumour cell adhesion in vitro. Biochim Biophys Acta 1660: 31–40. doi: 10.1016/j.bbamem.2003.10.014
[43]	Gajbhiye V, Ganesh N, Barve J, et al. (2013) Synthesis, characterization and targeting potential of zidovudine loaded sialic acid conjugated-mannosylated poly(propyleneimine) dendrimers. Eur J Pharm Sci 48: 668–679. doi: 10.1016/j.ejps.2012.12.027
[44]	Zhang WX, Dong DQ, Li P, et al. (2016) Novel pH-sensitive polysialic acid based polymeric micelles for triggered intracellular release of hydrophobic drug. Carbohyd Polym 139: 75–81. doi: 10.1016/j.carbpol.2015.12.041
[45]	Ray GB, Chakraborty I, Moulik SP (2006) Pyrene absorption can be a convenient method for probing critical micellar concentration (cmc) and indexing micellar polarity. J Colloid Interf Sci 294: 248–254. doi: 10.1016/j.jcis.2005.07.006
[46]	Hans M, Shimoni K, Danino D, et al. (2005) Synthesis and characterization of mPEG-PLA prodrug micelles. Biomacromolecules 6: 2708–2717. doi: 10.1021/bm050188k
[47]	Liang HC, Chang WH, Liang HF, et al. (2004) Crosslinking structures of gelatin hydrogels crosslinked with genipin or a water-soluble carbodiimide. J Appl Polym Sci 91: 4017–4026. doi: 10.1002/app.13563
[48]	Koo AN, Min KH, Lee HJ, et al. (2012) Tumor accumulation and antitumor efficacy of docetaxel-loaded core-shell-corona micelles with shell-specific redox-responsive cross-links. Biomaterials 33: 1489–1499. doi: 10.1016/j.biomaterials.2011.11.013
[49]	Lee H, Ahn CH, Park TG (2009) Poly lactic-co-(glycolic acid)-grafted hyaluronic acid copolymer micelle nanoparticles for target-specific delivery of doxorubicin. Macromol Biosci 9: 336–342. doi: 10.1002/mabi.200800229
[50]	Sutton D, Wang S, Nasongkia N, et al. (2007) Doxorubicin and beta-lapachone release and interaction with micellar core materials: experiment and modeling. Exp Biol Med 232: 1090–1099. doi: 10.3181/0702-RM-31
[51]	Donaldson O, Huang Z, Comolli N (2013) An integrated experimental and modeling approach to propose biotinylated PLGA microparticles as versatile targeting vehicles for drug delivery. Prog Biomat 2: 1–10. doi: 10.1186/2194-0517-2-1
[52]	Zhai S, Ma Y, Chen Y, et al. (2014) Synthesis of an amphiphilic block copolymer containing zwitterionic sulfobetaine as a novel pH-sensitive drug carrier. Polym Chem 5: 1285–1297. doi: 10.1039/C3PY01325A
[53]	Deshmukh AS, Chauhan PN, Malleshappa NN, et al. (2017) Polymeric micelles: Basic research to clinical practice. Int J Pharm 532: 249–268. doi: 10.1016/j.ijpharm.2017.09.005
[54]	Aftab S, Shah A, Nadhman A, et al. (2018) Nanomedicine: An effective tool in cancer therapy. Int J Pharm 540: 132–149. doi: 10.1016/j.ijpharm.2018.02.007

bioeng-05-02-106-s01.pdf

Reader Comments

Your name:*

Email:*
© 2018 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)